Gilead Sciences (GILD) Inventory (2009 - 2026)

Gilead Sciences (GILD) has reported Inventory for 18 consecutive years, with $1.9 billion the latest figure, recorded in Q1 2026.

• Inventory for Q1 2026 came in at $1.9 billion, up 8.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 billion (up 8.81% YoY), and the FY2025 annual result was $1.8 billion, up 3.74% from the prior year.
• Inventory was $1.9 billion for Q1 2026 at Gilead Sciences, up from $1.8 billion in the prior quarter.
• Over five years, Inventory peaked at $2.0 billion in Q2 2024 and troughed at $1.5 billion in Q3 2022.
• Average Inventory over 5 years is $1.7 billion, with a median of $1.8 billion recorded in 2025.
• Year-over-year, Inventory slipped 16.69% in 2022 and increased 24.07% in 2024.
• Over 5 years, Inventory stood at $1.5 billion in 2022, then climbed by 18.58% to $1.8 billion in 2023, then dropped by 4.31% to $1.7 billion in 2024, then climbed by 3.74% to $1.8 billion in 2025, then grew by 7.89% to $1.9 billion in 2026.
• Per Business Quant data, the three most recent Inventory figures were $1.9 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.8 billion in Q3 2025.